RELAFEN DS Trademark

Trademark Overview

On Monday, February 13, 2017, a trademark application was filed for RELAFEN DS with the United States Patent and Trademark Office. The USPTO has given the RELAFEN DS trademark a serial number of 87333917. The federal status of this trademark filing is REGISTERED as of Tuesday, December 24, 2019. This trademark is owned by Argent Development Group, LLC. The RELAFEN DS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of inflammation and pain, particularly with respect to the treatment of rheumatoid arthritis and osteoarthritis
relafen ds

General Information

Serial Number87333917
Word MarkRELAFEN DS
Filing DateMonday, February 13, 2017
Status700 - REGISTERED
Status DateTuesday, December 24, 2019
Registration Number5944501
Registration DateTuesday, December 24, 2019
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 11, 2017

Trademark Statements

Disclaimer with Predetermined Text"DS"
Goods and ServicesPharmaceutical preparations for the treatment of inflammation and pain, particularly with respect to the treatment of rheumatoid arthritis and osteoarthritis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 17, 2017
Primary Code005
First Use Anywhere DateWednesday, October 30, 2019
First Use In Commerce DateWednesday, October 30, 2019

Trademark Owner History

Party NameArgent Development Group, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressMountain View, CA 94040
Party NameArgent Development Group, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressMountain View, CA 94040
Party NameArgent Development Group, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressMountain View, CA 94040

Trademark Events

Event DateEvent Description
Tuesday, December 24, 2019REGISTERED-PRINCIPAL REGISTER
Thursday, November 21, 2019NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, November 20, 2019ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, November 19, 2019STATEMENT OF USE PROCESSING COMPLETE
Friday, November 8, 2019USE AMENDMENT FILED
Tuesday, November 19, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, November 8, 2019TEAS STATEMENT OF USE RECEIVED
Tuesday, May 14, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, May 12, 2019EXTENSION 4 GRANTED
Sunday, May 12, 2019EXTENSION 4 FILED
Sunday, May 12, 2019TEAS EXTENSION RECEIVED
Thursday, November 8, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 6, 2018EXTENSION 3 GRANTED
Tuesday, November 6, 2018EXTENSION 3 FILED
Tuesday, November 6, 2018TEAS EXTENSION RECEIVED
Thursday, May 10, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 8, 2018EXTENSION 2 GRANTED
Tuesday, May 8, 2018EXTENSION 2 FILED
Tuesday, May 8, 2018TEAS EXTENSION RECEIVED
Tuesday, November 14, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 10, 2017EXTENSION 1 GRANTED
Friday, November 10, 2017EXTENSION 1 FILED
Friday, November 10, 2017TEAS EXTENSION RECEIVED
Tuesday, June 6, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 11, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 11, 2017PUBLISHED FOR OPPOSITION
Wednesday, March 22, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, March 2, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 2, 2017ASSIGNED TO EXAMINER
Friday, February 17, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, February 16, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

relafen treatment rheumatoid arthritis respect osteoarthritis pain preparations inflammation pharmaceutical particularly